CN103773878B - Based on blood plasma microRNA detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR - Google Patents
Based on blood plasma microRNA detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR Download PDFInfo
- Publication number
- CN103773878B CN103773878B CN201410041147.5A CN201410041147A CN103773878B CN 103773878 B CN103773878 B CN 103773878B CN 201410041147 A CN201410041147 A CN 201410041147A CN 103773878 B CN103773878 B CN 103773878B
- Authority
- CN
- China
- Prior art keywords
- mirna
- mir
- specific
- plasma
- hsa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及microRNA,具体涉及一种基于AllGlo探针荧光定量PCR的血浆microRNA检测试剂盒及其检测方法。The invention relates to microRNA, in particular to a plasma microRNA detection kit based on AllGlo probe fluorescent quantitative PCR and a detection method thereof.
背景技术Background technique
MicroRNA(miRNA)是一类广泛存在于真核细胞中的长约22个核苷酸的非编码RNA分子,参与了在生物体中许多生理病理过程,通过调节基因表达,在细胞增殖、凋亡、生长发育、细胞分化、代谢等过程中发挥重要作用。具体表现为miRNA在细胞核内经过形成最初的初级转录本pri-miRNA到pre-miRNA,后转运出细胞核,通过剪切形成成熟miRNA,通过与Ago蛋白等形成RISC(RNA诱导的沉默复合体),部分抑制或降解靶mRNA序列,参与基因表达调控(BartelDP.MicroRNAs:genomics,biogenesis,mechanism,andfunction[J].Cell,2004,116(2):281-297.)。MicroRNA (miRNA) is a kind of non-coding RNA molecule of about 22 nucleotides widely present in eukaryotic cells, which participates in many physiological and pathological processes in organisms, by regulating gene expression, in cell proliferation, apoptosis , growth and development, cell differentiation, metabolism and other processes play an important role. The specific performance is that miRNA forms the initial primary transcript pri-miRNA to pre-miRNA in the nucleus, and then transports out of the nucleus, forms mature miRNA by shearing, and forms RISC (RNA-induced silencing complex) with Ago protein, etc. Partially inhibit or degrade the target mRNA sequence and participate in the regulation of gene expression (BartelDP. MicroRNAs: genomics, biogenesis, mechanism, and function [J]. Cell, 2004, 116(2): 281-297.).
由于miRNA在肿瘤的发生、发展、预后判断以及许多其他疾病状态下扮演着重要角色,精确检测其表达情况对于研究miRNA的作用具有重大意义,目前检测miRNA的方法主要有northernblot技术、实时荧光定量PCR技术、原位杂交技术、微阵列芯片技术等。其中northernblot技术是RNA检测的早期手段之一,但其特异性和敏感性低,如果样本RNA含量低或存在降解,可能检测不到;原位杂交技术用于检测组织和细胞水平miRNA的分布情况,同时对miRNA进行半定量检测,其不足之处在于不能准确检测到低表达的miRNA;微阵列芯片技术是一种高通量的检测技术,能同时检测一种或多种样本的大量的miRNA,但存在芯片制作费时、费力、标记成本高、检测灵敏度与特异性低等问题。Since miRNA plays an important role in tumor occurrence, development, prognosis judgment and many other disease states, accurate detection of its expression is of great significance for studying the role of miRNA. At present, the methods for detecting miRNA mainly include northern blot technology and real-time fluorescent quantitative PCR. technology, in situ hybridization technology, microarray chip technology, etc. Among them, northern blot technology is one of the early means of RNA detection, but its specificity and sensitivity are low. If the sample RNA content is low or there is degradation, it may not be detected; in situ hybridization technology is used to detect the distribution of miRNA at the tissue and cell level , while performing semi-quantitative detection of miRNA, its disadvantage is that it cannot accurately detect low-expression miRNA; microarray chip technology is a high-throughput detection technology that can simultaneously detect a large number of miRNAs in one or more samples , but there are problems such as time-consuming and labor-intensive chip fabrication, high labeling costs, and low detection sensitivity and specificity.
实时荧光定量技术(RT-qPCR)是目前最普遍用于基因表达检测的技术之一,具有简便快速、敏感性高和特异性好等特点。目前用于检测miRNA的实时荧光定量PCR方法包括RNA逆转录和下游的荧光定量PCR两部分,其中逆转录根据反转录引物的不同分为两种:同聚物加尾法和茎环逆转录法;荧光定量PCR的检测分为染料法和探针法,其中目前检测miRNA的探针多为Taqman-MGB探针(一种适合于扩增短片段的荧光探针)。由于成熟的miRNA具有片段短小的特点,要特异的检测,探针法更有优势,在敏感性和特异性上优于染料法。基于茎环结构的逆转录引物能特异识别,扩增成熟的miRNA序列,而miRNA的前体并未被扩增,Taqman-MGB探针检测miRNA的缺点在于合成价格贵,不利于推广。Real-time fluorescence quantitative technique (RT-qPCR) is one of the most commonly used techniques for gene expression detection, which is characterized by simplicity, rapidity, high sensitivity and good specificity. The real-time fluorescent quantitative PCR method currently used to detect miRNA includes two parts: RNA reverse transcription and downstream fluorescent quantitative PCR. The reverse transcription is divided into two types according to the different reverse transcription primers: homopolymer tailing method and stem-loop reverse transcription. The detection method of fluorescent quantitative PCR is divided into dye method and probe method, among which the probe for detecting miRNA is mostly Taqman-MGB probe (a fluorescent probe suitable for amplifying short fragments). Since the mature miRNA has the characteristics of short fragments, the probe method has more advantages for specific detection, and is superior to the dye method in terms of sensitivity and specificity. The reverse transcription primer based on the stem-loop structure can specifically recognize and amplify the mature miRNA sequence, but the precursor of miRNA has not been amplified. The disadvantage of Taqman-MGB probe detection of miRNA is that the synthesis is expensive, which is not conducive to popularization.
目前AllGlo探针已经成功应用于检测疱疹病毒、乙型肝炎病毒基因突变(Feng,Z.L.Yu,X.Y.Lu,Z.M.Geng,D.Y.Zhang,L.Chen,S.J.RapiddetectionofthehepatitisBvirusYMDDmutantusingAllGloTMprobes[J].ClinChimActa,2011,412(11-12):1018-1021)、侵袭性曲霉菌病(Wu,D.S.Shen,J.Z.Zhou,X.Q.Shen,S.F.Wu,X.M.TheestablishmentandevaluationofdiagnosticaccuracyofAllGlo(TM)probe-basedtechniquesforinvasiveaspergillosis[J].ZhonghuaNeiKeZaZhi,2010,49(2):142-145)、K-ras基因突变、强直性脊柱炎等检测。At present, AllGlo probes have been successfully applied to detect gene mutations of herpes virus and hepatitis B virus (Feng, ZLYu, XYLu, ZMGeng, DYZhang, L. Chen, SJ Rapid detection of the hepatitis B virus YMDD mutation using AllGlo TM probes [J]. ClinChimActa, 2011, 412 (11-12) : 1018-1021), invasive aspergillosis (Wu, DSShen, JZZhou, XQShen, SFWu, XM The establishment and evaluation of diagnostic accuracy of All Glo (TM) probe-based techniques for invasive aspergillosis [J]. ZhonghuaNeiKeZaZhi, 2010, 49 (2): 142K-145 Detection of gene mutation, ankylosing spondylitis, etc.
发明内容Contents of the invention
针对现有检测血浆miRNA方法中使用的试剂盒和检测方法存在的上述缺陷,本发明的第一个目的在于提供检测三种血浆miRNA的特异引物。In view of the above-mentioned defects in the kits and detection methods used in the existing plasma miRNA detection methods, the first purpose of the present invention is to provide specific primers for detection of three plasma miRNAs.
本发明的第二个目在于提供基于AllGlo探针荧光定量PCR的血浆miRNA检测试剂盒。The second object of the present invention is to provide a plasma miRNA detection kit based on AllGlo probe fluorescence quantitative PCR.
本发明的第三个目的在于提供一种基于AllGlo探针荧光定量PCR的三种血浆miRNA检测方法。The third object of the present invention is to provide a method for detecting three plasma miRNAs based on AllGlo probe fluorescent quantitative PCR.
所述三种血浆miRNA分别是指hsa-miR-504、hsa-miR-133b、cel-miR-39;其中hsa-miR-504与hsa-miR-133b为人源性miRNA,cel-miR-39为线虫来源的miRNA,作为一种外源性参照miRNA,从血浆提取开始加入血浆中,作用在于能够从提取miRNA开始监测整个实时荧光定量PCR的全过程。The three plasma miRNAs refer to hsa-miR-504, hsa-miR-133b, and cel-miR-39 respectively; wherein hsa-miR-504 and hsa-miR-133b are human-derived miRNAs, and cel-miR-39 is The nematode-derived miRNA, as an exogenous reference miRNA, is added to the plasma from plasma extraction, and its function is to be able to monitor the whole process of real-time fluorescent quantitative PCR from the extraction of miRNA.
所述检测三种血浆miRNA的特异引物包括三种血浆miRNA特异性逆转录引物和三种血浆miRNA特异性正向引物;The specific primers for detecting three plasma miRNAs include three plasma miRNA specific reverse transcription primers and three plasma miRNA specific forward primers;
所述三种血浆miRNA特异性逆转录引物由hsa-miR-504的特异性逆转录引物、hsa-miR-133b的特异性逆转录引物和cel-miR-39的特异性逆转录引物组成;The three plasma miRNA specific reverse transcription primers are composed of hsa-miR-504 specific reverse transcription primers, hsa-miR-133b specific reverse transcription primers and cel-miR-39 specific reverse transcription primers;
所述hsa-miR-504的特异性逆转录引物的核苷酸序列为SEQIDNO.15'-GTCGTATCCAGTGCGTGTCGTGGAGTCGGCAATTGCACTGGATACGACGATAGAGT-3';The nucleotide sequence of the hsa-miR-504 specific reverse transcription primer is SEQ ID NO.15'-GTCGTATCCAGTGCGTGTCGTGGAGTCGGCAATTGCACTGGATACGACGATAGAGT-3';
所述hsa-miR-133b的特异性逆转录引物的核苷酸序列为SEQIDNO.25'-GTCGTATCCAGTGCGTGTCGTGGAGTCGGCAATTGCACTGGATACGACTAGCTGGT-3';The nucleotide sequence of the specific reverse transcription primer of hsa-miR-133b is SEQ ID NO.25'-GTCGTATCCAGTGCGTGTCGTGGAGTCGGCAATTGCACTGGATACGACTAGCTGGT-3';
所述cel-miR-39的特异性逆转录引物的核苷酸序列为SEQIDNO.35'-GTCGTATCCAGTGCGTGTCGTGGAGTCGGCAATTGCACTGGATACGACCAAGCTGA-3'。The nucleotide sequence of the specific reverse transcription primer of cel-miR-39 is SEQ ID NO. 35'-GTCGTATCCAGTGCGTGTCGTGGAGTCGGCAATTGCACTGGATACGACCAAGCTGA-3'.
所述三种血浆miRNA特异性正向引物由hsa-miR-504的特异性正向引物、hsa-miR-133b的特异性正向引物和cel-miR-39的特异性正向引物组成;The three plasma miRNA-specific forward primers are composed of hsa-miR-504 specific forward primers, hsa-miR-133b specific forward primers and cel-miR-39 specific forward primers;
所述hsa-miR-504的特异性正向引物的核苷酸序列为SEQIDNO.45'-GCTGGTTAAGACCCTGGT-3';The nucleotide sequence of the hsa-miR-504 specific forward primer is SEQ ID NO.45'-GCTGGTTAAGACCCTGGT-3';
所述hsa-miR-133b的特异性正向引物核苷酸序列为SEQIDNO.55'-TAGCGTCTTTGGTCCCCT-3';The specific forward primer nucleotide sequence of hsa-miR-133b is SEQ ID NO.55'-TAGCGTCTTTGGTCCCCT-3';
所述cel-miR-39的特异性正向引物的核苷酸序列为SEQIDNO.65'-CAGAGTCACCGGGTGTAAAT-3'。The nucleotide sequence of the specific forward primer of cel-miR-39 is SEQ ID NO.65'-CAGAGTCACCGGGTGTAAAT-3'.
所述三种血浆miRNA特异性AllGlo探针由hsa-miR-504的特异性AllGlo探针、hsa-miR-133b的特异性AllGlo探针和cel-miR-39的特异性AllGlo探针组成;The three plasma miRNA specific AllGlo probes are composed of hsa-miR-504 specific AllGlo probes, hsa-miR-133b specific AllGlo probes and cel-miR-39 specific AllGlo probes;
所述hsa-miR-504的特异性AllGlo探针的核苷酸序列为SEQIDNO.7MAR-CTGGATACGACGATAGAGTGC-MAR;The nucleotide sequence of the hsa-miR-504-specific AllGlo probe is SEQ ID NO. 7MAR-CTGGATACGACGATAGAGTGC-MAR;
所述hsa-miR-133b的特异性AllGlo探针的核苷酸序列为SEQIDNO.8JUP-CTGGATACGACTAGCTGGTTGA-JUP;The nucleotide sequence of the specific AllGlo probe of hsa-miR-133b is SEQ ID NO.8JUP-CTGGATACGACTAGCTGGTTGA-JUP;
所述cel-miR-39的特异性AllGlo探针的核苷酸序列为SEQIDNO.9NEP-TGCACTGGATACGACCAAGCT-NEP。The nucleotide sequence of the specific AllGlo probe of cel-miR-39 is SEQ ID NO.9NEP-TGCACTGGATACGACCAAGCT-NEP.
所述三种血浆miRNA的通用引物序列的核苷酸序列为SEQIDNO.105'-CAGTGCGTGTCGTGGAGT-3'。The nucleotide sequence of the universal primer sequence of the three plasma miRNAs is SEQ ID NO. 105'-CAGTGCGTGTCGTGGAGT-3'.
所述基于AllGlo探针荧光定量PCR的血浆microRNA检测试剂盒设有盒体、隔板、miRNA提取试剂瓶、茎环逆转录试剂瓶、实时荧光定量PCR试剂瓶;隔板设在盒体内,miRNA提取试剂瓶、茎环逆转录试剂瓶、实时荧光定量PCR试剂瓶插在隔板上,miRNA提取试剂瓶内装有miRNA提取试剂,茎环逆转录试剂瓶内装有茎环逆转录试剂,实时荧光定量PCR试剂瓶内装有实时荧光定量PCR试剂。The plasma microRNA detection kit based on AllGlo probe fluorescent quantitative PCR is provided with a box body, a partition, a miRNA extraction reagent bottle, a stem-loop reverse transcription reagent bottle, and a real-time fluorescent quantitative PCR reagent bottle; the partition is arranged in the box body, and the miRNA Extraction reagent bottles, stem-loop reverse transcription reagent bottles, and real-time fluorescence quantitative PCR reagent bottles are inserted on the partition plate, miRNA extraction reagent bottles are filled with miRNA extraction reagents, and stem-loop reverse transcription reagent bottles are filled with stem-loop reverse transcription reagents for real-time fluorescence quantitative The PCR reagent bottle is equipped with real-time fluorescent quantitative PCR reagents.
所述miRNA提取试剂包括血浆miRNA外源性参照,所述血浆miRNA外源性参照是指人工合成的cel-miR-39的模拟物(人工合成的cel-miR-39的模拟物作为一种外源性加入的参照,其工作浓度为5nmol,作用在于能够监测从提取microRNA到后面实时荧光定量PCR全过程的反应效率)。The miRNA extraction reagent includes plasma miRNA exogenous reference, and the plasma miRNA exogenous reference refers to the artificially synthesized cel-miR-39 mimic (the artificially synthesized cel-miR-39 mimic serves as an exogenous The working concentration of the original added reference is 5nmol, which is used to monitor the reaction efficiency of the whole process from microRNA extraction to real-time fluorescent quantitative PCR).
所述茎环逆转录试剂包括以下组份:200单位/μL的MMLV酶、10mmoldNTP混合液、5×RT缓冲液(5×RT缓冲液由250mmolTris-HCl,375mmolKCl,15mmolMgCl2,50mmolDTT组成)、40单位/μL的RNA酶抑制剂、10mmol的MgCl2、1μmol的特异的miRNA的逆转录引物、miRNA标准品(这里的miRNA标准品是指人工合成的miRNA,浓度为100nmol)。The stem-loop reverse transcription reagent includes the following components: 200 units/μL of MMLV enzyme, 10mmoldNTP mixture, 5×RT buffer (5×RT buffer consists of 250mmol Tris-HCl, 375mmol KCl, 15mmolMgCl 2 , 50mmol DTT), 40 Unit/μL of RNase inhibitor, 10 mmol of MgCl 2 , 1 μmol of specific miRNA reverse transcription primer, and miRNA standard (the miRNA standard here refers to artificially synthesized miRNA with a concentration of 100 nmol).
所述实时荧光定量PCR试剂包括以下组份:10×Taq缓冲液(10×Taq缓冲液包括100mmolTris-HCl,500mmolKCl)、10mmol的MgCl2、5单位/μL的Taq聚合酶、10mMdNTP混合液、100ml无核酶水、10μmol特异正向引物、10μmol通用反向引物和AllGlo探针。The real-time fluorescent quantitative PCR reagent includes the following components: 10×Taq buffer (10×Taq buffer includes 100mmol Tris-HCl, 500mmol KCl), 10mmol of MgCl 2 , 5 units/μL of Taq polymerase, 10mMdNTP mixture, 100ml Nuclease-free water, 10 μmol specific forward primer, 10 μmol universal reverse primer and AllGlo probe.
所述基于AllGlo探针荧光定量PCR的血浆microRNA检测方法,包括以下步骤:The plasma microRNA detection method based on AllGlo probe fluorescence quantitative PCR, comprises the following steps:
1.在200μL血浆充分裂解后加入所述基于AllGlo探针荧光定量PCR的血浆miRNA检测试剂盒中提供的工作浓度为5nmol的血浆miRNA外源性参照,立即进行漩涡震荡15s,其余步骤同常规方法;1. After 200 μL of plasma is fully lysed, add the plasma miRNA exogenous reference with a working concentration of 5 nmol provided in the plasma miRNA detection kit based on AllGlo probe fluorescent quantitative PCR, and immediately vortex for 15 seconds, and the rest of the steps are the same as the conventional method ;
2.应用所述基于AllGlo探针荧光定量PCR的血浆miRNA检测试剂盒提供的茎环逆转录试剂将miRNA逆转录为cDNA;2. Using the stem-loop reverse transcription reagent provided by the plasma miRNA detection kit based on AllGlo probe fluorescence quantitative PCR, the miRNA is reverse-transcribed into cDNA;
3.应用所述基于AllGlo探针荧光定量PCR的血浆miRNA检测试剂盒提供的实时荧光定量PCR试剂将cDNA进行实时荧光定量PCR扩增;3. Apply the real-time fluorescent quantitative PCR reagent provided by the plasma miRNA detection kit based on AllGlo probe fluorescent quantitative PCR to carry out real-time fluorescent quantitative PCR amplification of cDNA;
4.综合分析仪器给出的各项数据,设定合理的阈值(Threshold)和基线(Baseline),进行结果分析。4. Comprehensively analyze the various data given by the instrument, set a reasonable threshold (Threshold) and baseline (Baseline), and analyze the results.
所述AllGlo探针可采用美国A1leLogicBiosciencesCorporation公司的荧光定量探针,它拥有普通Taqman,Taqman-MGB及分子信标(molecularbeacon)探针所有优点,去掉了目前这几种探针的最大弊端,它打破了传统Taqman一端报告基团一端淬灭基团的限制,利用了美国A1leLogicBiosciencesCorporation公司研制的几种常见波长的特制荧光染料,标记在寡核苷酸上面互为报告基团和粹灭基团,而且上面含有特殊的可以提高Tm值(退火温度)的化学基团,提高探针特异性,杂交特异性大大提高,在杂交水解之后两端标记的染料又全部变为报告基团,提高荧光增量。The AllGlo probe can adopt the fluorescent quantitative probe of AlleLogic Biosciences Corporation of the United States, which has all the advantages of common Taqman, Taqman-MGB and molecular beacon (molecular beacon) probes, and removes the biggest drawback of these several probes at present. To overcome the limitation of the traditional Taqman reporter group at one end and the quencher group at the other end, the special fluorescent dyes with several common wavelengths developed by AleLogic Biosciences Corporation of the United States are used to mark each other on the oligonucleotide as the reporter group and the quencher group, and It contains a special chemical group that can increase the Tm value (annealing temperature), improve the specificity of the probe, and greatly improve the hybridization specificity. After the hybridization hydrolysis, all the dyes labeled at both ends become reporter groups, increasing the fluorescence increment. .
所述AllGlo探针具有以下优势:①提高Tm值(可达10℃以上),探针更短可以达到15~16个碱基,可以适用A,T含量比较高的序列设计探针;②加大了多重荧光定量的选择,因为每种染料即是报告基团又是淬灭基团,打破传统Taqman探针因波长原因标记选择困难,不受淬灭基团波长限制;③大大提高信噪比,无背景信号,空间距离近,更好的淬灭效果;④成本较低,价格仅相当于Taqman-MGB探针的一半,具有MGB探针所有优势。The AllGlo probe has the following advantages: ① Increase the Tm value (up to 10°C or more), the shorter probe can reach 15-16 bases, and it can be used to design probes for sequences with relatively high A and T content; ② Add Increase the choice of multiple fluorescence quantification, because each dye is both a reporter group and a quencher group, which breaks the difficulty of label selection due to the wavelength of the traditional Taqman probe, and is not limited by the wavelength of the quencher group; ③ greatly improves the signal-to-noise ratio, no background signal, close spatial distance, and better quenching effect; ④ lower cost, the price is only half of that of Taqman-MGB probes, and has all the advantages of MGB probes.
本发明采用了AllGlo探针技术,设计了三种特异正向引物和特异探针和通用反向引物,三种探针两端只需分别标记三种特殊荧光基团(MAR、JUP、NEP),能够同时检测三种miRNA,并对该技术反应条件进行优化,建立了一种基于AllGlo探针技术联合实时荧光定量PCR技术同时检测三种血浆miRNA的方法,应用前景广阔。The present invention adopts the AllGlo probe technology, and designs three kinds of specific forward primers, specific probes and universal reverse primers. The two ends of the three probes only need to be labeled with three special fluorescent groups (MAR, JUP, NEP). , can simultaneously detect three miRNAs, and optimize the reaction conditions of this technology, and establish a method based on AllGlo probe technology combined with real-time fluorescent quantitative PCR technology to simultaneously detect three plasma miRNAs, which has broad application prospects.
本发明采用了AllGlo探针技术,建立了能检测miRNA的实时荧光定量PCR的方法,与Taqman-MGB探针法相比,线性范围均能达到7个数量级。本发明建立的实时荧光定量PCR灵敏度最低可达10拷贝/μL,最高可达107拷贝/μL。The present invention adopts the AllGlo probe technology and establishes a real-time fluorescent quantitative PCR method capable of detecting miRNA. Compared with the Taqman-MGB probe method, the linear range can reach 7 orders of magnitude. The sensitivity of the real-time fluorescence quantitative PCR established by the present invention can be as low as 10 copies/μL and as high as 10 7 copies/μL.
本发明的有益效果如下:The beneficial effects of the present invention are as follows:
本发明提供了一种检测miRNA基于AllGlo探针RT-qPCR的检测方法和试剂盒,其特异性和敏感性高,可快速准确检测样本中miRNA的含量,与现有技术相比具有以下优势:The present invention provides a detection method and kit based on AllGlo probe RT-qPCR for detecting miRNA, which has high specificity and sensitivity, can quickly and accurately detect the content of miRNA in a sample, and has the following advantages compared with the prior art:
1.与northernblot,miRNA芯片相比,AllGlo探针检测的特异性和敏感性均要高,价格比microRNA芯片要便宜;1. Compared with northern blot and miRNA chips, the specificity and sensitivity of AllGlo probe detection are higher, and the price is cheaper than microRNA chips;
2.与taqman-MGB探针相比,AllGlo探针采用相同的荧光基团,互为报告基团和淬灭基团,一方面释放的荧光信号更强,另一方面本底信号更低;而且合成程序简单,价格仅相当于taqman-MGB的一半。2. Compared with the taqman-MGB probe, the AllGlo probe uses the same fluorescent group, which acts as a reporter group and a quencher group for each other. On the one hand, the released fluorescent signal is stronger, and on the other hand, the background signal is lower; Moreover, the synthesis procedure is simple, and the price is only equivalent to half of taqman-MGB.
3.本发明建立了基于AllGlo探针的RT-qPCR检测miRNA方法,适合于做为芯片筛选miRNA的的后期临床样本验证,以及研究miRNA在不同领域的差异性表达等,推动了miRNA在相关疾病的深入研究。3. The present invention establishes an RT-qPCR method for detecting miRNA based on AllGlo probes, which is suitable for later stage clinical sample verification of microarray screening miRNA, as well as research on differential expression of miRNA in different fields, etc., which promotes miRNA in related diseases in-depth research.
附图说明Description of drawings
图1为本发明实施例基于AllGlo探针荧光定量PCR的血浆microRNA检测试剂盒的结构组成示意图。FIG. 1 is a schematic diagram of the structure and composition of a plasma microRNA detection kit based on AllGlo probe fluorescent quantitative PCR according to an embodiment of the present invention.
图2为AllGlo探针实时荧光定量PCR检测三种标准品混合液中hsa-miR-133b(人源性miR-133b)的扩增曲线图。Figure 2 is the amplification curve of hsa-miR-133b (human-derived miR-133b) detected in three standard mixtures by AllGlo probe real-time fluorescent quantitative PCR.
图3为AllGlo探针实时荧光定量PCR检测三种标准品混合液中hsa-miR-133b(人源性miR-133b)的标准曲线图。Fig. 3 is a standard curve diagram of hsa-miR-133b (human miR-133b) detected in three standard mixtures by AllGlo probe real-time fluorescent quantitative PCR.
具体实施方式detailed description
实施例1Example 1
参见图1,本发明所述基于AllGlo探针荧光定量PCR的血浆microRNA检测试剂盒实施例设有盒体1、隔板2、miRNA提取试剂瓶3、茎环逆转录试剂瓶4、实时荧光定量PCR试剂瓶5;隔板2设在盒体1内,miRNA提取试剂瓶3、茎环逆转录试剂瓶4、实时荧光定量PCR试剂瓶5插在隔板2上,miRNA提取试剂瓶3内装有miRNA提取试剂,茎环逆转录试剂瓶4内装有茎环逆转录试剂,实时荧光定量PCR试剂瓶5内装有实时荧光定量PCR试剂。Referring to Fig. 1, the plasma microRNA detection kit embodiment based on AllGlo probe fluorescence quantitative PCR of the present invention is provided with box body 1, partition 2, miRNA extraction reagent bottle 3, stem-loop reverse transcription reagent bottle 4, real-time fluorescence quantitative PCR reagent bottle 5; Partition plate 2 is located in box body 1, miRNA extraction reagent bottle 3, stem-loop reverse transcription reagent bottle 4, real-time fluorescent quantitative PCR reagent bottle 5 are inserted on the partition plate 2, and miRNA extraction reagent bottle 3 is equipped with The miRNA extraction reagent, the stem-loop reverse transcription reagent bottle 4 is equipped with a stem-loop reverse transcription reagent, and the real-time fluorescent quantitative PCR reagent bottle 5 is equipped with a real-time fluorescent quantitative PCR reagent.
所述miRNA提取试剂包括血浆miRNA外源性参照,所述血浆miRNA外源性参照是指人工合成的cel-miR-39的模拟物(人工合成的cel-miR-39的模拟物做为一种外源性加入的参照,其工作浓度为5nmol,作用在于能够监测从提取microRNA到后面实时荧光定量PCR全过程的反应效率)。The miRNA extraction reagent includes plasma miRNA exogenous reference, and the plasma miRNA exogenous reference refers to the artificially synthesized cel-miR-39 mimic (the artificially synthesized cel-miR-39 mimic is used as a The working concentration of exogenously added reference is 5nmol, which is used to monitor the reaction efficiency of the whole process from microRNA extraction to real-time fluorescent quantitative PCR).
所述茎环逆转录试剂包括以下组份:200单位/μL的MMLV酶、10mmoldNTP混合液、5×RT缓冲液(5×RT缓冲液由250mmolTris-HCl,375mmolKCl,15mmolMgCl2,50mmolDTT组成)、40单位/μL的RNA酶抑制剂、10mmol的MgCl2、1μmol的特异的miRNA的逆转录引物、miRNA标准品(这里的miRNA标准品是指人工合成的miRNA,浓度为100nmol)。The stem-loop reverse transcription reagent includes the following components: 200 units/μL of MMLV enzyme, 10mmoldNTP mixture, 5×RT buffer (5×RT buffer consists of 250mmol Tris-HCl, 375mmol KCl, 15mmolMgCl 2 , 50mmol DTT), 40 Unit/μL of RNase inhibitor, 10 mmol of MgCl 2 , 1 μmol of specific miRNA reverse transcription primer, and miRNA standard (the miRNA standard here refers to artificially synthesized miRNA with a concentration of 100 nmol).
所述实时荧光定量PCR试剂包括以下组份:10×Taq缓冲液(10×Taq缓冲液包括100mmolTris-HCl,500mmolKCl)、10mmol的MgCl2、5单位/μL的Taq聚合酶、10mMdNTP混合液、100ml无核酶水、10μmol特异正向引物、10μmol通用反向引物和AllGlo探针。The real-time fluorescent quantitative PCR reagent includes the following components: 10×Taq buffer (10×Taq buffer includes 100mmol Tris-HCl, 500mmol KCl), 10mmol of MgCl 2 , 5 units/μL of Taq polymerase, 10mMdNTP mixture, 100ml Nuclease-free water, 10 μmol specific forward primer, 10 μmol universal reverse primer and AllGlo probe.
实施例2Example 2
本发明的具体操作步骤及反应体系如下:Concrete operating steps of the present invention and reaction system are as follows:
1.提取miRNA1. Extraction of miRNA
采用天根生物科技有限公司的生产的miRNA提取试剂盒,按照操作说明书进行样本(血浆)microRNA提取,其中200μL血浆在加入等体积裂解液静置5min后加入外源性参照cel-mir395μL(工作浓度为5nmol),后按照说明书操作进行,最后用30μL的去核酶水溶解RNA,于核酸分光光度仪器NanoDrop2000上分别测定浓度和纯度,取2~20ng的已提取的miRNA用于下游的逆转录,其余的miRNA均于-80℃冻存。The miRNA extraction kit produced by Tiangen Biotechnology Co., Ltd. was used to extract the microRNA from the sample (plasma) according to the operating instructions. Among them, 200 μL of plasma was added to an equal volume of lysate and allowed to stand for 5 minutes, and then 395 μL of exogenous reference cel-mir (working concentration) was added. 5nmol), then follow the instructions, and finally dissolve the RNA with 30 μL of denuclease water, measure the concentration and purity on the nucleic acid spectrophotometer NanoDrop2000, and take 2-20ng of the extracted miRNA for downstream reverse transcription. All other miRNAs were frozen at -80°C.
2.miRNA的逆转录:2. Reverse transcription of miRNA:
2.1将逆转录所需成分于室温下溶解,震荡混匀后置于冰上;2.1 Dissolve the components required for reverse transcription at room temperature, shake and mix well, and place on ice;
2.2配制逆转录反应混合液,按表1进行配制:2.2 Prepare the reverse transcription reaction mixture according to Table 1:
表1Table 1
2.3在0.2μL的独立PCR管中每管分装2.3 Aliquot each tube in separate 0.2 μL PCR tubes
将配好的18μL混合液分装于无RNA酶的PCR管中,后加入2μL已提取富集的miRNA溶液,用无RNA酶枪头充分混匀(此操作尽量避免气泡的产生),短暂离心甩至管底后置于普通PCR仪(Biorad公司生产)上,逆转录反应条件如表2。Dispense 18 μL of the prepared mixture into RNase-free PCR tubes, then add 2 μL of the extracted and enriched miRNA solution, mix thoroughly with RNase-free pipette tips (try to avoid the generation of air bubbles during this operation), and centrifuge briefly Throw it to the bottom of the tube and place it on an ordinary PCR instrument (produced by Biorad Company). The reverse transcription reaction conditions are shown in Table 2.
表2Table 2
反应结束后置于4℃。Place at 4°C after the reaction is complete.
3.miRNA的荧光定量PCR检测3. Fluorescent quantitative PCR detection of miRNA
3.1将荧光定量PCR的各组分置于室温溶解,混匀后置于冰上。3.1 Dissolve the components of fluorescent quantitative PCR at room temperature, mix well and place on ice.
3.2配制PCR反应混合液如表3。3.2 Prepare the PCR reaction mixture as shown in Table 3.
表3table 3
3.3于8联管中分装配制好PCR反应混合液,每管加入2μL的cDNA,充分混匀,整个过程在冰上进行,避免气泡的产生。3.3 Dispense and prepare the PCR reaction mixture in 8 tubes, add 2 μL of cDNA to each tube, and mix well. The whole process is carried out on ice to avoid the generation of air bubbles.
3.4荧光定量PCR反应反应条件如表4。3.4 Fluorescent quantitative PCR reaction The reaction conditions are shown in Table 4.
表4Table 4
检测在实时荧光定量PCR仪器上进行,可使用ABI7300,7500(美国AppliedBiosystems公司)等多种仪器。The detection is carried out on a real-time fluorescent quantitative PCR instrument, and various instruments such as ABI7300 and 7500 (Applied Biosystems, USA) can be used.
4.数据分析与标准化处理:应用SPSS13.0以及Excel2007进行数据分析,用上述方法可测的样本血浆中目标miRNA和外源性参照cel-mir-39的CT值,根据外源性参照的CT值水平求得目的miRNA在血浆中的相对含量,以qPCR中相对定量的2-ΔCt方式表示血浆中目的miRNA的水平(ΔCt为目的microRNA与外源性参照的Ct值之差)。4. Data analysis and standardization processing: SPSS13.0 and Excel2007 were used for data analysis, and the CT values of the target miRNA in the sample plasma and the exogenous reference cel-mir-39 measured by the above method, according to the CT value of the exogenous reference The relative content of the target miRNA in the plasma was obtained at the value level, and the level of the target miRNA in the plasma was expressed in the form of relative quantitative 2 -ΔCt in qPCR (ΔCt is the difference between the Ct value of the target microRNA and the exogenous reference).
实施例3Example 3
3种miRNA混合的荧光定量PCR反应体系及标准曲线的建立如表5。The fluorescent quantitative PCR reaction system and the establishment of the standard curve of the three miRNA mixtures are shown in Table 5.
表5table 5
预先将3种microRNA标准品稀释至5×107拷贝/μL的miRNA起始浓度,进行混合后,进行连续10倍稀释,后进行RT-qPCR检测,以hsa-miR-133b为例,其扩增曲线和标准曲线如图2和3。Dilute the three microRNA standards in advance to the initial miRNA concentration of 5×10 7 copies/μL. After mixing, perform serial 10-fold dilutions, and then perform RT-qPCR detection. Taking hsa-miR-133b as an example, its amplification The increasing curve and standard curve are shown in Figures 2 and 3.
实施例4Example 4
临床样本检测:Clinical sample testing:
选取患者血浆样本各5例,应用AllGlo探针法检测hsa-miR-133b,与美国的lifetechnologies公司的检测hsa-miR-133b的microRNATaqmanMGB的方法进行比较,分别做2个复孔。Select 5 cases of plasma samples from each patient, and use the AllGlo probe method to detect hsa-miR-133b, and compare it with the microRNATaqmanMGB method of hsa-miR-133b detected by American lifetechnologies company, and make 2 duplicate holes.
三种方法分别检测5例结直肠癌组织样本中hsa-miR-133b的结果比较如表6。Table 6 compares the results of three methods for detecting hsa-miR-133b in 5 cases of colorectal cancer tissue samples.
表6Table 6
说明:检测同一个样本,CT值越低说明敏感性越高,从上表的数据显示:与Taqman-MGB探针法检测5个不同的样本相比,单重AllGlo探针法和三重AllGlo探针法在检测血浆样本has-miR-133b的CT值要低于Taqman-MGB探针法,说明两者的敏感性要明显高于Taqman-MGB探针法。Explanation: When detecting the same sample, the lower the CT value, the higher the sensitivity. The data in the above table shows that compared with the detection of 5 different samples by the Taqman-MGB probe method, the single AllGlo probe method and the triple AllGlo probe method The CT value of has-miR-133b in plasma samples detected by the needle method is lower than that of the Taqman-MGB probe method, indicating that the sensitivity of the two methods is significantly higher than that of the Taqman-MGB probe method.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410041147.5A CN103773878B (en) | 2014-01-28 | 2014-01-28 | Based on blood plasma microRNA detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410041147.5A CN103773878B (en) | 2014-01-28 | 2014-01-28 | Based on blood plasma microRNA detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103773878A CN103773878A (en) | 2014-05-07 |
CN103773878B true CN103773878B (en) | 2015-12-30 |
Family
ID=50566634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410041147.5A Active CN103773878B (en) | 2014-01-28 | 2014-01-28 | Based on blood plasma microRNA detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103773878B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104195238B (en) * | 2014-08-15 | 2017-08-01 | 深圳市晋百慧生物有限公司 | Label and its application for detecting intestinal cancer |
CN105671038A (en) * | 2016-03-02 | 2016-06-15 | 厦门大学附属中山医院 | miR-19a detection kit based on AllGlo probe fluorescence quantitative PCR and detection method thereof |
CN113604564A (en) * | 2017-08-14 | 2021-11-05 | 江苏为真生物医药技术股份有限公司 | Method for detecting exosome-associated microRNA (ribonucleic acid) molecules |
CN107904303A (en) * | 2017-11-30 | 2018-04-13 | 广州市妇女儿童医疗中心 | For detecting the primer sets of 140 3p of biliary atresia children blood plasma miR and detection kit comprising the primer sets |
-
2014
- 2014-01-28 CN CN201410041147.5A patent/CN103773878B/en active Active
Non-Patent Citations (3)
Title |
---|
AllGloTM Slides-CHI’s PCR & Beyond,McLean,VA, July 21-23,2004;Shane Xin;《allelogic biosciences corp》;20040723;Slide第18、21页 * |
STEM-LOOP RT-qPCR for miRNAs;Martha F. Kramer;《Curr Protoc Mol Biol》;20110701;摘要、第1-2页跨页段、第2页第4段、第3页第8行-第5页最后一行、图15.10.1、图15.10.2 * |
血清microRNA可作为弥漫大B细胞淋巴瘤诊断理想的生物标志物;方成等;《中国科技论文在线》;20130304;材料方法 * |
Also Published As
Publication number | Publication date |
---|---|
CN103773878A (en) | 2014-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090075258A1 (en) | Methods of Normalization in microRNA Detection Assays | |
CN103773878B (en) | Based on blood plasma microRNA detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
WO2023025259A1 (en) | Method and kit for detecting microrna | |
CN103757122B (en) | Based on hsa-miR-188-5p detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103740850B (en) | Based on hsa-miR-9 detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103757124B (en) | Based on hsa-miR-629-5p detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103740853B (en) | Based on hsa-miR-134 detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103740845B (en) | Based on hsa-miR-513b detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103757121B (en) | Based on hsa-miR-489 detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103740849B (en) | Hsa-miR-124 (Human Serum Albumin-Micro Ribonucleic Acid-124) detection kit and hsa-miR-124 detection method based on AllGlo probe fluorescent quantitative PCR (Polymerase Chain Reaction) | |
CN115895857A (en) | PCR chip and method for detecting micro RNA in blood sample | |
CN103773877B (en) | MicroRNA detection kit and detection method thereof is organized based on AllGlo fluorescence probe quantitative PCR | |
CN105671038A (en) | miR-19a detection kit based on AllGlo probe fluorescence quantitative PCR and detection method thereof | |
CN103740852B (en) | Based on hsa-miR-137 detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103773873B (en) | Based on hsa-miR-26a-2 detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103773875B (en) | Based on hsa-miR-1323 detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103740847B (en) | Based on hsa-miR-339-5p detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103740851B (en) | Based on hsa-miR-191-5p detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103757125B (en) | Based on hsa-miR-625-5p detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103757123B (en) | Based on hsa-miR-646 detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103740844B (en) | Based on hsa-miR-132 detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103740846B (en) | Based on hsa-miR-1321 detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103773874B (en) | Based on hsa-miR-363 detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103773879B (en) | Based on hsa-miR-708 detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR | |
CN103740848B (en) | Based on hsa-miR-146 detection kit and the detection method thereof of AllGlo fluorescence probe quantitative PCR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |